Skip to main content

Table 2 Studies included in the systematic review

From: A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas

MicroRNA

Cancer type

Biofluid type

Deregulation

Author

Reference

miR-125b

Bladder cancer

Urine

↓ tumors vs controls

Zhang et al.

46

↓ high-grades vs low-grades

Uveal Melanoma

Plasma

↑tumors vs controls

Achberger et al.

47

Advanced Melanoma

Seruma

↓tumors vs controls

Alegre et al.

48

Ewing’s sarcoma

Serum

↓ tumors vs controls

Nie et al.

49

Breast cancer

Serum

↑ late stages vs controls

Wang et al.

50

↑ late stages vs early stages

Breast cancer

Urine

↓ tumors vs controls

Erbes et al.

51

Breast cancer

Serum

↑ tumors vs controls

Mar-Aguilar et al.

52

Breast cancer

Serum

↑ tumors vs controls

Matamala et al.

53

Non-small-cell lung cancer

Serum

↑ tumorsvs controls

Yuxia et al.

54

↑ late stages vs early stages

Non-small-cell lung cancer

Plasma

↑ tumors vs controls

Zhao et al.

55

↑ late stages vs early stages

Diffuse large B-cell lymphoma

Serum

↑ tumors vs controls

Yuan et al.

56

Laryngeal squamous cell carcinoma

Plasma

↓ tumors vs controls

Ayaz et al.

57

Glioma

Serum

↓ tumors vs controls

Wei et al.

32

↓ high-grades vs low-grades

Colorectal neoplasia

Serum

↑ tumors vs controls

Yamada et al.

58

miR-497

Bladder cancer

Plasma

↓ tumors vs controls

Du et al.

59

Astrocytoma

Serum

↓ tumors vs controls

Yang et al.

26

Nasopharyngeal carcinoma

Plasma

↓ tumors vs controls

Wang et al.

60

Prostate cancer

Serum

↓ tumors vs controls

Kong et al.

61

Cervical cancer

Serum

↑ tumors vs controls

Zhang et al.

62

  1. aExosomal fraction only